National Institute of Allergy and Infectious Diseases (NIAID): all 2,445 studies

Page 22 of 25. Open to participants first (182), then studies with results posted, then the rest; newest registration first within each.

• A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC)CompletedNCT00000978Phase 1
• Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and ToxicityCompletedNCT00000977Phase 1
• A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4-Immunoglobulin G (rCD4-IgG) Administered by Intravenous Bolus Injection in Combination With Oral Zidovudine in Patients With AIDS and AIDS-Related ComplexCompletedNCT00000976Phase 1
• A Study of Itraconazole in the Treatment and Prevention of Histoplasmosis, a Fungal Infection, in Patients With AIDSCompletedNCT00000975Phase 2
• A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii PneumoniaCompletedNCT00000974Phase 1
• A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive PatientsCompletedNCT00000973Phase 1
• A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59CompletedNCT00000972Phase 1
• A Study of Foscarnet Plus Ganciclovir in the Treatment of Cytomegalovirus of the Eye in Patients With AIDS Who Have Already Been Treated With GanciclovirCompletedNCT00000970Phase 1
• A Prospective, Randomized, Open-Label, Comparative Trial of Dideoxyinosine (ddI) Versus Dideoxycytidine (ddC) in HIV-Infected Patients Who Are Intolerant of or Who Have Failed Zidovudine (AZT) TherapyCompletedNCT00000969Not applicable
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived HIV-1 Recombinant Envelope Glycoprotein (gp160)CompletedNCT00000968Phase 1
• The Safety of Zidovudine Plus Interferon-Alpha in HIV-Infected ChildrenCompletedNCT00000967Phase 1
• The Effects of Zidovudine on the Blood of HIV-Infected PatientsCompletedNCT00000965Not applicable
• The Effect of Stomach Acid on FoscarnetCompletedNCT00000964Phase 1
• A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take ZidovudineCompletedNCT00000963Phase 2
• The Safety and Effectiveness of BI-RG-587 in HIV-Infected PatientsCompletedNCT00000962Phase 1
• The Safety and Effectiveness of Hyperimmune Anti-HIV Intravenous Immunoglobulin (HVIG) Plus Zidovudine in HIV-Infected InfantsTerminatedNCT00000961Phase 2
• The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their InfantsCompletedNCT00000960Phase 3
• Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Suspected Latent Tuberculous InfectionCompletedNCT00000959Not applicable
• A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)CompletedNCT00000958Phase 1
• A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated SchedulesCompletedNCT00000957Phase 1
• A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160CompletedNCT00000956Phase 1
• Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) InfectionCompletedNCT00000955Not applicable
• A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's SarcomaCompletedNCT00000954Phase 1
• Comparison of Brovavir Versus Acyclovir in the Treatment of Herpes in HIV-Infected PatientsCompletedNCT00000953Phase 2
• A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and ChildrenCompletedNCT00000952Phase 1
• A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent ThrushCompletedNCT00000951Phase 4
• Metabolism of Antituberculosis Drugs in HIV-Infected Persons With TuberculosisCompletedNCT00000950Not applicable
• A Study to Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3CompletedNCT00000949Phase 3
• Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3CompletedNCT00000948Phase 2
• A Study to Evaluate the Effects of Azithromycin on MAC Disease Prevention in HIV-Positive PatientsCompletedNCT00000947Not applicable
• A Study to Test the Safety of Three Experimental HIV VaccinesCompletedNCT00000946Phase 1
• A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS PatientsCompletedNCT00000945Not applicable
• A Study to Evaluate the Safety and Tolerance of Combination Anti-HIV Drug Therapy (Indinavir, Lamivudine, and Zidovudine) in HIV-Positive Pregnant Women and Their InfantsCompletedNCT00000944Phase 1
• A Study to Test If Giving Remune (an HIV Vaccine) Can Improve the Immune Systems of HIV-Positive Patients Who Are Also Participating in ACTG 328CompletedNCT00000943Not applicable
• A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their BabiesCompletedNCT00000942Phase 3
• A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your BloodCompletedNCT00000941Phase 1
• Five-Drug Anti-HIV Treatment Followed by Treatment Interruption in Patients Who Have Recently Been Infected With HIVCompletedNCT00000940Phase 2
• A Study to Compare the Effectiveness of Different Anti-HIV Drug Regimens in Keeping Levels of HIV in the Blood as Low as PossibleCompletedNCT00000939Phase 2
• A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme DiseaseCompletedNCT00000938Phase 3
• Study and Treatment of Post Lyme Disease (STOP-LD)CompletedNCT00000937Phase 3
• A Study To Test An Anti-Rejection Therapy After Kidney TransplantationTerminatedNCT00000936Phase 3
• An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant AntigensCompletedNCT00000935Phase 3
• Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048CompletedNCT00000933
• A Study of the Long-Term Outcomes of HIV-Positive PatientsCompletedNCT00000932
• HIV Prevention Counseling for Men Who Have Sex With MenCompletedNCT00000931Phase 3
• A Study of HIV in Newly Infected IndividualsCompletedNCT00000930
• A Study of the Effects of Advantage 24 on the RectumCompletedNCT00000929Phase 1
• Phase I Trial of an Intervention to Increase Condom Use by HIV-Discordant CouplesCompletedNCT00000928Phase 1
• A Study of BufferGel in WomenCompletedNCT00000927Phase 1
• A Study of Nonoxynol-9 (N-9) and HIV InfectionCompletedNCT00000926Phase 3
• A Study to Evaluate High Protein Supplementation in HIV-Positive Patients With Stable Weight LossCompletedNCT00000925Phase 2
• A Study to Compare Two Different Anti-HIV Drug RegimensCompletedNCT00000924Phase 2
• Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328CompletedNCT00000923Not applicable
• A Study to Evaluate the Long-Term Effectiveness of Three Anti-HIV Drug Regimens in HIV Infected Patients Who Have Never Been Exposed to Highly Active Antiretroviral Therapy (HAART)CompletedNCT00000922Not applicable
• The Effects of Prednisone on HIV Levels and the Immune SystemCompletedNCT00000921Phase 2
• Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their NewbornsCompletedNCT00000920Phase 1
• A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV InfectionCompletedNCT00000919Not applicable
• A Study to Compare The Ability of Different Anti-HIV Drugs to Decrease Viral Load After Nelfinavir (an Anti-HIV Drug)Treatment FailureCompletedNCT00000918Phase 2
• Setting up a Blood Bank for Gene Therapy in HIV-Infected InfantsTerminatedNCT00000917
• A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their BloodCompletedNCT00000916Phase 2
• An HIV Vaccine Preparedness StudyCompletedNCT00000915Not applicable
• A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 WeeksCompletedNCT00000914Not applicable
• A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive ChildrenCompletedNCT00000913Phase 2
• A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive PatientsCompletedNCT00000912Phase 2
• A Study to Monitor Patients With Primary or Early HIV InfectionCompletedNCT00000911
• A Study to Collect Information About HIV-Positive Pregnant Women and Their BabiesCompletedNCT00000910
• A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV TherapyCompletedNCT00000909Phase 2
• A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell CountsCompletedNCT00000908
• A Study to Examine the Effects of Stopping Preventive Therapy for Disseminated Mycobacterium Avium Complex (DMAC) in HIV-Positive PatientsCompletedNCT00000907
• Interactions of HIV Protease Inhibitors and Methadone in HIV-Infected PatientsCompletedNCT00000906Phase 1
• A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV TherapyCompletedNCT00000905
• Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative AdultsCompletedNCT00000904Phase 1
• Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment RegimenCompletedNCT00000903Phase 3
• A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior TreatmentCompletedNCT00000902Phase 1
• Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected ChildrenCompletedNCT00000901Phase 1
• The Effects of Illnesses on HIV Levels in the BodyCompletedNCT00000900
• A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive PatientsCompletedNCT00000899Phase 1
• The Effects of Staggered Dosing on Interactions Between Paired Combinations of Nelfinavir, Ritonavir, and SaquinavirCompletedNCT00000898Not applicable
• A Study to Evaluate the Effects of Different Methods of Birth Control on the Drug Actions of Zidovudine (an Anti-HIV Drug) in HIV-Positive Women and to Compare Zidovudine Metabolism in Men and WomenCompletedNCT00000897Not applicable
• A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive PatientsCompletedNCT00000896Not applicable
• A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV InfectionCompletedNCT00000895Not applicable
• Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV RetinitisCompletedNCT00000894Phase 4
• Safety, Tolerability, and Anti-HIV Activity of DMP 266 (Efavirenz) in Combination With Nelfinavir in HIV-Positive ChildrenCompletedNCT00000893Phase 1
• A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used IndinavirCompletedNCT00000892Not applicable
• Immunologic and Virologic Consequences of Long-Term Highly Active Antiretroviral Therapy (HAART) in Subjects With Moderately Advanced HIV-1 Disease: A Follow-Up Study to ACTG 315CompletedNCT00000891Phase 2
• A Study to Evaluate the Effect of Anti-HIV Therapy on Lean Tissue (Muscle) in HIV-Positive PatientsCompletedNCT00000890
• A Study to Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3CompletedNCT00000889Phase 2
• Safety and Effectiveness of Ritonavir Plus Lamivudine Plus Zidovudine in HIV-Infected Pregnant Women and Their BabiesCompletedNCT00000888Phase 1
• A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their InfantsCompletedNCT00000887Phase 1
• A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)CompletedNCT00000886Phase 1
• Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320CompletedNCT00000885Phase 2
• A Randomized Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP205 Delivered by Alternate Mucosal Routes in HIV-1 Uninfected Adult VolunteersCompletedNCT00000884Phase 1
• Long-Term Assessment for Metabolic, Cardiovascular and Neurologic Problems in HIV-Infected Patients With Increased CD4 Cells Counts Following Anti-HIV TherapyCompletedNCT00000883Not applicable
• Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced SubjectsCompletedNCT00000882Phase 2
• A Study of Cidofovir in HIV-Infected Children With Cytomegalovirus (CMV) DiseaseWithdrawnNCT00000881Phase 1
• A Study to Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV DiseaseCompletedNCT00000880Phase 2
• A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive MothersCompletedNCT00000879Phase 1
• A Study to Evaluate the Safety and Tolerance of Stavudine (d4T) in Combination With Lamivudine (3TC) in HIV-Positive Pregnant Women and Their InfantsCompletedNCT00000878Phase 1
• Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative AdultsCompletedNCT00000877Phase 1
• Safety and Effectiveness of CD4-IgG2 in HIV-Positive ChildrenCompletedNCT00000876Phase 1

← National Institute of Allergy and Infectious Diseases (NIAID) overview and focus areas